Paper Review Records
全部论文审稿周期
12 篇有效样本 · 按发表日期由新到旧排列
审稿天数=录用日期-收稿日期；保留 PDF/DOI/网页源链接
24
天
Prognostic relevance and molecular correlates of Claudin-1 expression in pancreatic neuroendocrine tumors
作者
Antonin Fattori; Xiaofan Lu; Philippe Baltzinger; Philippe Bachellier; Pietro Addeo; Alessio Imperiale; Patrick Pessaux; Jean-Emmanuel Kurtz; Bernard Goichot; Thomas F. Baumert; Marie-Pierrette Chenard; Gabriel G. Malouf展开收起
作者单位
Department of Cancer and Functional Genomics, Institute of Genetics and Molecular and Cellular Biology, CNRS/INSERM/UNISTRA, Illkirch, France; Department of Pathology, Strasbourg University Hospitals, Strasbourg, France; Department of Endocrinology, Diabetology and Nutrition, Strasbourg University Hospitals, Strasbourg, France; Department of Hepato-Pancreato-Biliary Surgery and Liver Transplantation, Strasbourg University Hospitals, Strasbourg, France; Department of Nuclear Medicine, Strasbourg University Hospitals, Strasbourg, France; Department of Digestive and Endocrine Surgery, Strasbourg University Hospitals, Strasbourg, France; Department of Medical Oncology, Strasbourg University Hospitals, Strasbourg, France; University of Strasbourg, Inserm, Institute for Translational Medicine and Liver Disease (ITM), UMR_1110, Strasbourg, France; Gastroenterology and Hepatology Service, Strasbourg University Hospitals, Strasbourg, France; IHU Strasbourg, Strasbourg, France; Institut Universitaire de France, Paris, France展开收起
149
天
Artificial intelligence-assisted screening for NTRK fusion-positive salivary gland tumors: A novel digital pathology workflow
作者
Ryutaro Onaga; Shingo Sakashita; Daisuke Komura; Nobuyuki Nakamura; Makoto Tahara; Genichiro Ishii; Tohru Ikeda; Shumpei Ishikawa展开收起
作者单位
Department of Head and Neck Medical Oncology, National Cancer Center Hospital East, Kashiwa, Japan; Department of Otolaryngology and Head and Neck Surgery, Jichi Medical University, Tochigi, Japan; Department of Clinical Oncology, Jichi Medical University, Tochigi, Japan; Division of Pathology, National Cancer Center, Exploratory Oncology Research & Clinical Trial Center, Kashiwa, Japan; Department of Pathology and Clinical Laboratories, National Cancer Center Hospital East, Kashiwa, Japan; Department of Preventive Medicine, The University of Tokyo, Tokyo, Japan; Department of Clinical Laboratories, National Cancer Center Hospital East, Kashiwa, Japan; Department of Oral Pathology, Graduate School of Medical and Dental Sciences, Institute of Science Tokyo, Tokyo, Japan展开收起
36
天
Evaluation of prognostic factors and outcomes in primary versus secondary myeloid sarcoma: Evaluating primary vs. secondary myeloid sarcoma
作者
Christine W. Kahlow; Sharon Germans; Maximiliano Ramia de Cap; Adam Bagg; Wei Du; Stephanie Hurwitz; Daniel A. Arber; Andrew Hermina; Falko Fend; Dominik Nann; Weina Chen; Mingyi Chen; Miguel D. Cantu; Wayne Tam; Carlos R. Bueso-Ramos; Rashmi Kanagal-Shamanna; Philipp W. Raess; Alexa Siddon; Tracy I. George; Kathryn Foucar; Robert P. Hasserjian; Olga K. Weinberg展开收起
作者单位
Department of Hematopathology, University of Texas Southwestern Medical Center, Dallas, TX, USA; Imperial College Healthcare NHS Trust, London, UK; Department of Pathology and Laboratory Medicine, Hospital of the University of Pennsylvania, Philadelphia, PA, USA; Department of Pathology, The University of Chicago, Chicago, IL, USA; Institute of Pathology and Neuropathology, Eberhard Karls University of Tübingen and Comprehensive Cancer Center, University Hospital Tübingen, Tübingen, Germany; Department of Pathology and Laboratory Medicine, Weill Cornell Medical College, New York, NY, USA; Department of Hematopathology, Division of Pathology/Lab Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, USA; Department of Pathology and Laboratory Medicine, Oregon Health & Science University, Portland, OR, USA; Department of Pathology, Yale School of Medicine, New Haven, CT, USA; ARUP Laboratories, Salt Lake City, UT, USA; Department of Pathology, University of Utah School of Medicine, Salt Lake City, UT, USA; Department of Pathology, University of New Mexico School of Medicine, Albuquerque, NM, USA; Department of Pathology, Harvard Medical School, Boston, MA, USA; Department of Pathology, Massachusetts General Hospital, Boston, MA, USA展开收起
54
天
A report of thirteen non-conventional FLCN-mutated (renal) tumors (FMT) and a discussion of proposed diagnostic criteria, convergent FLCN/TFEB and FLCN/MITF E318K signaling, and FLCN immunohistochemistry
作者
Sounak Gupta; Rosalie M. Sterner; Hisashi Hasumi; Ryosuke Jikuya; Hidewaki Nakagawa; Oleksandr N. Kryvenko; Merce Jorda; Nate R. Torell; Zinandre Stander; Robert G. Colef; Burak Tekin; Rumeal D. Whaley; Loren Herrera Hernandez; Rafael E. Jimenez; Peter C. Lucas; Benjamin R. Kipp; Wei Shen; Lori A. Erickson; Surendra Dasari; John C. Cheville展开收起
作者单位
Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, MN, USA; Department of Urology, Yokohama City University, Yokohama, Japan; RIKEN Center for Integrative Medical Sciences, Yokohama, Japan; Department of Pathology and Laboratory Medicine, University of Miami Miller School of Medicine, Miami, FL, USA; Department of Quantitative Health Sciences, Mayo Clinic, Rochester, MN, USA展开收起
60
天
The Farooq, not the Lerner, grading system predicts disease-specific and overall survival in duodenal graft-versus-host disease
作者
Bei Yang; Reem Youssef; Omer Saeed; Iván A. González展开收起
作者单位
Department of Pathology and Laboratory Medicine, Indiana University School of Medicine, Indianapolis, IN, USA展开收起
62
天
Histologic spectrum of BRCA-associated pancreatic ductal adenocarcinoma: A descriptive morphologic study
作者
Gali Zabarsky-Shasha; Maria Raitses-Gurevich; Chani Stossel; Talia Golan; Michael Schvimer; Iris Barshack; Chen Mayer展开收起
作者单位
Institute of Pathology, Sheba Medical Center, Tel-Hashomer, Israel; The Judisman Cancer Center, Sheba Medical Center, Tel-Hashomer, Israel; Faculty of Medicine, Tel Aviv University展开收起
Expert Matching · Case Demo
把投稿要求，转成可验证的期刊方案
说清专业、时限和作者背景，CrushSCI 结合真实审稿样本，给出拟题方向、期刊初筛与周期判断。
客户询问
我是环境工程专业，需要一篇 SCI，希望 3 个月内见刊。没有基金，也没有大牛挂名，可以投哪些期刊？
CrushSCI回复
可以。先按 90 天时限做可行性筛选，同步查找无基金、无知名作者挂靠的典型论文案例，作为选刊依据。重点核对研究质量与期刊 scope。
- 拟题建议
- 《融合机器学习与生命周期评价的城市污水处理碳排放预测与优化》
样本口径2026 年最近 5 篇有效论文样本
平均审稿62 天
中位数65 天